Cargando…

Corrigendum: Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation

Detalles Bibliográficos
Autores principales:	Bidlingmaier, Martin, Biller, Beverly M.K., Clemmons, David, Jørgensen, Jens Otto L., Nishioka, Hiroshi, Takahashi, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022694/ https://www.ncbi.nlm.nih.gov/pubmed/36936137 http://dx.doi.org/10.3389/fendo.2023.1158214

Ejemplares similares

Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
por: Bidlingmaier, Martin, et al.
Publicado: (2022)

Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency
por: Takahashi, Yutaka, et al.
Publicado: (2022)

Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly
por: Clemmons, David R., et al.
Publicado: (2023)

Tissue Distribution and Receptor Activation by Somapacitan, a Long Acting Growth Hormone Derivative
por: Petersen, Maj, et al.
Publicado: (2020)

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations
por: Christiansen, Jens Sandahl, et al.
Publicado: (2016)

Similar safety and efficacy in previously treated adults with growth hormone deficiency randomized to once‐weekly somapacitan or daily growth hormone
por: Otsuka, Fumio, et al.
Publicado: (2020)

Corrigendum: Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogues
por: Yuen, Kevin C. J., et al.
Publicado: (2021)

SAT-LB12 Once-Weekly Somapacitan vs Daily Growth Hormone in Growth Hormone Deficiency: 2-Year Safety Results From Real 3, a Randomized Phase 2 Trial
por: Savendahl, Lars S, et al.
Publicado: (2020)

SAT-LB074 Efficacy and Safety of Once-weekly Somapacitan in Adult Growth Hormone Deficiency (AGHD) Confirmed in a 53‑week Real 1 Trial Extension
por: Johannsson, Gudmundur, et al.
Publicado: (2019)

Usefulness and Potential Pitfalls of Long-Acting Growth Hormone Analogs
por: Yuen, Kevin C. J., et al.
Publicado: (2021)

Growth Hormone-Releasing Hormone in Diabetes
por: Fridlyand, Leonid E., et al.
Publicado: (2016)

Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency
por: Kildemoes, Rasmus Juul, et al.
Publicado: (2022)

Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis
por: Ma, Liyan, et al.
Publicado: (2021)

SUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)
por: Savendahl, Lars, et al.
Publicado: (2019)

Retraction: Effect of weekly long-acting growth hormone replacement therapy compared to daily growth hormone on children with short stature: a meta-analysis
por: Office, Frontiers Editorial
Publicado: (2023)

Optimal Monitoring of Weekly IGF-I Levels During Growth Hormone Therapy With Once-Weekly Somapacitan
por: Juul Kildemoes, Rasmus, et al.
Publicado: (2020)

What do we do now that the long-acting growth hormone is here?
por: Miller, Bradley S.
Publicado: (2022)

MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults
por: Strasburger, Christian J, et al.
Publicado: (2016)

RF26 | PMON335 Once-Weekly Somapacitan Versus Daily Growth Hormone in Children Born Small for Gestational Age: Results From a Randomized Phase 2 Trial
por: Juul, Anders, et al.
Publicado: (2022)

Adult Growth Hormone Deficiency – Benefits, Side Effects, and Risks of Growth Hormone Replacement
por: Reed, Mary L., et al.
Publicado: (2013)

Persistence with daily growth hormone among children and adolescents with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

RF26 | PMON334 Once-Weekly Somapacitan in Growth Hormone Deficiency: 4-Year Efficacy and Safety Results from REAL 3, a Randomised Controlled Phase 2 Trial
por: Savendahl, Lars, et al.
Publicado: (2022)

Genetic Defects in the Growth Hormone–IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth
por: Savage, Martin O., et al.
Publicado: (2011)

Growth Hormone and Endometrial Receptivity
por: Altmäe, Signe, et al.
Publicado: (2019)

Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone Deficiency
por: Gonzalez, Susana, et al.
Publicado: (2018)

The Use of IGF-I to Monitor Long-Acting Growth Hormone Therapy—Timing is an Art…
por: Bidlingmaier, Martin, et al.
Publicado: (2021)

Investigation of the metabolic and endocrinological differences between daily and weekly growth hormone replacement therapy, somapacitan, in patients with adult growth hormone deficiency: A real-world pilot study
por: Abe, Ichiro, et al.
Publicado: (2023)

The Intricate Role of Growth Hormone in Metabolism
por: Vijayakumar, Archana, et al.
Publicado: (2011)

Application of Growth Hormone in in vitro Fertilization
por: Xu, Yue-Ming, et al.
Publicado: (2019)

The role of growth hormone in assisted reproduction
por: Quaas, Alexander M., et al.
Publicado: (2022)

Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review
por: Zendran, Iga, et al.
Publicado: (2022)

Corrigendum: Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial
por: Sun, Chengjun, et al.
Publicado: (2021)

Growth Hormone Stimulation Testing Patterns Contribute to Gender Disparities in Growth Hormone Treatment
por: Kamoun, Camilia, et al.
Publicado: (2021)

Estrogens Regulate the Hepatic Effects of Growth Hormone, a Hormonal Interplay with Multiple Fates
por: Fernández-Pérez, Leandro, et al.
Publicado: (2013)

Managing Transition in Patients Treated with Growth Hormone
por: Hauffa, Berthold P., et al.
Publicado: (2017)

Glucose Metabolism in Children With Growth Hormone Deficiency
por: Ciresi, Alessandro, et al.
Publicado: (2018)

A Case with Spondyloenchondrodysplasia Treated with Growth Hormone
por: Utsumi, Takanori, et al.
Publicado: (2017)

Editorial: History of Growth Hormone: Animal to Human
por: Reiter, Edward O., et al.
Publicado: (2021)

Editorial: Controversies in growth hormone treatment and diagnosis
por: Rapaport, Robert, et al.
Publicado: (2022)

Criteria for First-Year Growth Response to Growth Hormone Treatment in Prepubertal Children With Growth Hormone Deficiency: Do They Predict Poor Adult Height Outcome?
por: Straetemans, Saartje, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kip3kh3udm88fch12q39nc9ubr